articles about health in About 333

Of the 122 articles published on Pig333 last year by world-renowned authors, these were the ten most-read. You won't want to miss a single one.

The 333 Experience Congress Latam 2024, held over three days in Costa Rica, brought together more than 1,000 participants, 27% of whom were directors and managers of leading Latin American swine companies. Thirty-eight percent of the attendees were from Costa Rica, and more than 60% came from other countries.

Innovation and international collaboration drive the evolution of the swine industry in Africa.

We'd like to thank all the users who participated in the PCV-2 vaccine survey and congratulate the winners of the drawing.

For yet another year and uninterruptedly since 2012, 333 will be present at the leading scientific meeting of the global swine industry.

Biocheck is an innovative tool that objectively quantifies and compares the level of biosecurity on swine farms, identifying areas for improvement.

We have developed a practical and visual swine necropsy manual.

Join us in revisiting the articles that have resonated the most with our dedicated swine community throughout 2023.

The congress was distinguished by the participation of relevant industry leaders, its academic excellence and learning methodologies, and the networking spaces, bringing together more than 1,300 people from all over the region.

A look back on the hottest topics of the year from Pig333.

Presenting the new interactive world map of ASF outbreaks, updated weekly from WOAH data.

On May 11, 12, and 13, the first online "333 Experience Congress" took place in Spain.

Round Table on PRRS with M. Torremorell, E. Mateu, and J. Baliellas. The latest addition to the Experience program!

This tool serves as a guide to diagnose diseases in pigs and is available on the website, as well as for iOs and Android.

Take a look back at our most popular articles of the year and make sure you didn’t miss one of the most-read articles.

It has been 20 years since wasting disease appeared. Are vaccines still effective? Has the disease's epidemiology changed? Should we be concerned about new PCV2 strains or PCV3?